Mitchell Shawnte Insider Trades

Insider Trading History

Track insider trading activity for Mitchell Shawnte. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $2.45k 233 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$606k 25,000 shares
$24.25
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $4.31M 410,000 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$609k 25,000 shares
$24.34
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $263k 25,000 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$609k 25,000 shares
$24.34
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $4.57M 435,000 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$351k 15,000 shares
$23.43
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $0 0 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$345k 15,000 shares
$23.01
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $158k 15,000 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$351k 15,000 shares
$23.43
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $2.31M 220,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.09M 276,250 shares
$25.65
$10.51
Olema Pharmaceuticals
Olema Pharmaceuticals OLMA
CHIEF LEGAL OFFICER
Holding Value $4.73M 450,000 shares
Last Trade
Feb 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 450,000 shares
$4.37
$10.51
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $677k 134,800 shares
Last Trade
Feb 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.6B 134,800 shares
$227,008.40
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $607k 120,968 shares
Last Trade
Nov 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8B 120,968 shares
$262,563.80
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $414k 82,539 shares
Last Trade
Mar 01, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.86B 6,787 shares
$715,668.80
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $404k 80,527 shares
Last Trade
Mar 01, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.44B 2,012 shares
$715,668.80
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $0 0 shares
Last Trade
Mar 01, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.86B 6,787 shares
$715,668.80
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $338k 67,400 shares
Last Trade
Feb 28, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.7B 67,400 shares
$692,876.80
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $380k 75,752 shares
Last Trade
Aug 09, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$786M 383 shares
$2,051,280.00
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $34.1k 6,787 shares
Last Trade
Aug 09, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.34B 1,630 shares
$2,051,280.00
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $382k 76,135 shares
Last Trade
Aug 09, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.34B 1,630 shares
$2,051,280.00
$5.02
Aptevo Therapeutics
Aptevo Therapeutics APVO
Svp, GC And Corporate Affairs
Holding Value $0 0 shares
Last Trade
Aug 01, 2018 Sale
$217B 110,614 shares
$1,964,670.40
$5.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up